A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Saved in:
| Title: | A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study. |
|---|---|
| Authors: | Serhan M; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Psihogios A; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Kabir N; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Bota AB; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Mithani SS; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Smith DP; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada.; Institute of Mental Health Research, University of Ottawa, Ottawa, Canada., Zhu DT; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.; Yale School of Public Health, Yale University, New Haven, CT, USA., Greyson D; School of Population and Public Health, University of British Columbia, Vancouver, Canada., Wilson S; Health Protection, Public Health Ontario, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Populations & Public Health Research Program, ICES, Toronto, ON, Canada., Fell D; Department of Pediatrics, Children's Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Top KA; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.; Departments of Pediatrics and Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada., Bettinger JA; Vaccine Evaluation Center, Department of Pediatrics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada., Wilson K; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Canada.; O'Neill Institute for National and Global Health Law, Georgetown University.; Bruyère Research Institute, Ottawa, Canada. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2293550. Date of Electronic Publication: 2024 Feb 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Scoping Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2164-554X |
|---|---|
| DOI: | 10.1080/21645515.2023.2293550 |
